Tag Archives: drug

Medical technology platforms with high growth potential

Specific technologies and broad technology platforms have tremendous potential for market growth based on combinations of recent technology advancement, changes in clinical practice, current forces in the market and other criterial.  Biotech solutions to traditional medical device technologies.  The thrust of medical technology is, and has been for a long time, to make it as effective [...]

Where to invest? How about in innovation?

The recent formation of an index focused on health product innovators illustrates both the upside and the stability of the medtech arena.  The index includes companies which get approvals for drugs or biological agents classified as new chemical entities (i.e. excluding all new formulations of existing drugs, generic drugs, and label extensions for existing products). Also, companies [...]

Economy catches up with biotech investing (no surprise)

If you simply compare the average development times of pharmaceuticals, biotech and medical devices, you will see that medical devices demonstrate the shortest time from conception to market (or rejection). Devices, by virtue of providing, in many cases, a simple mechanical function — flatten atherosclerotic plaque against the lumen (angioplasty), keep it there (stents), close [...]

Medical Technology Market Analysis, MedMarkets (April 2008)

Below is the coverage in the April 2008 issue of MedMarkets. Ablation:  An Energized Market Demand for Hip and Knee Implants Expected to Increase MedMarket Outlook: Beyond Technology Innovation: Current and Future Market Forces and Trends Early Stage Companies: Evalve, ES Vascular, Cardiorobotics, TriVascular Early Stage Company Financings: Alure Medical, Arbel Medical, Breathe Technologies, CoAxia, [...]

Obesity Management Products Segment Sales Growth

The revenues to be had from the clinical management of obesity, whether derived from pharmaceutical or device sales, are forecast to see double-digit growth through 2015. Although revenues have been dampened by the FDA’s negative reaction to Sanofi-Aventis’ application for rimonabant, there are other drug compounds in late stages of testing which may prove to [...]

“High Growth Medical Technologies” 2008

We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing. As all white papers should be, it’s free.  Here’s the link so you can download it. bookmark to

New medtech company startups, March 2008

New medical technologies represented in companies added (March 2008) to the Medtech Startups Database and/or added to the March 2008 issue of MedMarkets: Cardiac rhythm monitor. Diagnosis of pediatric vesicoureteral reflux. Developing atherectomy for peripheral vascular disease. Systems to facilitate arthroscopic surgery. Bioimplants for surgery. Instrumentation for use in laparoscopic surgery. Interbody spacers for spine [...]